Lymphoma clinical trials
1,872 studies are looking for volunteers right now. Search near you to see which are close by and who can take part.
Or see all lymphoma studies in TrialFinder. Live data from ClinicalTrials.gov, updated daily.
At a glance
Where the studies are
U.S. states with the most recruiting lymphoma studies. A study counts once in each state where it has a site.
- California263
- Texas238
- New York236
- Florida185
- Ohio178
- Massachusetts154
- Pennsylvania140
- North Carolina129
- Washington126
- Illinois122
- Tennessee117
- Maryland113
Also in China (623), Italy (173), France (169), Spain (131), Australia (115), United Kingdom (112), Germany (108), Canada (102).
Types of study
Phases 1 to 4 test medicines, from first safety checks to long-term follow-up after approval. Trials of devices and programs have no phase. Observational studies give no study treatment.
- Early phase 151
- Phase 1305
- Phase 1 / Phase 2253
- Phase 2531
- Phase 2 / Phase 334
- Phase 3110
- Phase 423
- No phase (devices, programs)221
- Observational344
Recently updated studies
Recruiting lymphoma studies whose listing changed most recently. Open one in TrialFinder to check if you might qualify.
- RecruitingPhase 2NCT06124157
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Ages 366 Days – 46 Years · Birmingham, Alabama · Phoenix, Arizona +137 more · National Cancer Institute (NCI)
- RecruitingPhase 1NCT06441331
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
Ages 24 Months – 18 Years · Palo Alto, California · San Francisco, California +7 more · ITM Solucin GmbH
- RecruitingObservationalNCT06459024
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
Ages 6 Years and over · Aachen, Germany · Greifswald, Germany +33 more · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
- RecruitingPhase 1NCT02508038
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
Ages 7 Months – 21 Years · Madison, Wisconsin · University of Wisconsin, Madison
- RecruitingPhase 2NCT07593482
Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion in Chimeric Antigen Receptor T-cell Immunotherapy (CAR-T): a Randomized Trial.
Ages 18 Years and over · Aarau, Switzerland · Basel, Switzerland +7 more · Swiss Cancer Institute
- RecruitingPhase 2NCT07029737
A Study to Evaluate Acalabrutinib, in Combination With the R-CHOP Standard of Care, for Previously Untreated Mantle Cell Lymphoma in Spain
Ages 18 Years – 130 Years · A Coruña, Spain · Alcorcón, Spain +15 more · AstraZeneca
- RecruitingPhase 3NCT06713837
IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.
Ages 18 Years and over · Brno, Czechia · Hradec Králové, Czechia +42 more · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
- RecruitingPhase 1NCT06904066
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Ages 18 Years – 120 Years · Bethesda, Maryland · National Cancer Institute (NCI)
Worth knowing
- Taking part is your choice, and you can stop at any time.
- Each study has rules about who can join. The study team checks them with you before you start.
- Talk to your doctor about whether a study is a good fit for you.